of fiscal years 2021 through 2025 an amount equal to the savings described in paragraph (2). (2) Corresponding reduction The savings described in this paragraph is the amount authorized to be appropriated by provisions of law other than this section for the period of fiscal years 2021 through 2025 for Federal research and health care program activities related to prostate cancer, reduced by the amount of Federal savings projected to be achieved over such period by implementation of this section. 703. Prostate research, imaging, and men’s education (PRIME) (a) Short title This section may be cited as the Prostate Research, Imaging, and Men’s Education Act of 2020 or the PRIME Act of 2020 . (b) Findings Congress makes the following findings: (1) Prostate cancer has reached epidemic proportions, particularly among African-American men, and strikes and kills men in numbers comparable to the number of women who lose their lives from breast cancer. (2) Life-saving breakthroughs in screening, diagnosis, and treatment of breast cancer resulted from the development of advanced imaging technologies led by the Federal Government. (3) Men should have accurate and affordable prostate cancer screening exams and minimally invasive treatment tools, similar to what women have for breast cancer. (4) While it is important for men to take advantage of current prostate cancer screening techniques, a recent NCI-funded study demonstrated that the most common available methods of detecting prostate cancer (PSA blood test and physical exams) are not foolproof, causing numerous false alarms and false reassurances. (5) The absence of advanced imaging technologies for prostate cancer causes the lack of accurate information critical for clinical decisions, resulting in missed cancers and lost lives, as well as unnecessary and costly medical procedures, with related complications. (6) With prostate imaging tools, men and their families would face less physical, psychological, financial and emotional trauma and billions of dollars could be